Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M29,493Revenue $M9,766Net Margin (%)1.0Altman Z-Score0.7
Enterprise Value $M60,643EPS $1.8Operating Margin %17.3Piotroski F-Score6
P/E(ttm)57.7Beneish M-Score-2.1Pre-tax Margin (%)1.1Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %10.5Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %55.9Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow16.0y-y EBITDA Growth Rate %36.3ROA % (ttm)0.2Higher Current Ratio y-yY
Dividend Yield %--PEG1.2ROE % (ttm)1.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M343ROIC % (ttm)-13.3Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXLou Simpson 2015-12-31 Add2.51%$70.32 - $182.32
($111.15)
$ 87.28-21%Add 38.18%2,698,614
VRXKen Fisher 2015-12-31 Sold Out $70.32 - $182.32
($111.48)
$ 87.28-22%Sold Out0
VRXLeon Cooperman 2015-09-30 Buy 1.75%$158.08 - $262.52
($233.19)
$ 87.28-63%New holding484,915
VRXSteve Mandel 2015-09-30 Add1.62%$158.08 - $262.52
($233.19)
$ 87.28-63%Add 40.52%7,461,780
VRXLou Simpson 2015-09-30 Add1.35%$158.08 - $262.52
($233.19)
$ 87.28-63%Add 13.00%1,952,983
VRXGlenn Greenberg 2015-09-30 Reduce-0.79%$158.08 - $262.52
($233.19)
$ 87.28-63%Reduce -2.16%5,577,892
VRXWallace Weitz 2015-09-30 Reduce-0.54%$158.08 - $262.52
($233.19)
$ 87.28-63%Reduce -12.08%630,155
VRXChris Davis 2015-09-30 Reduce-0.2%$158.08 - $262.52
($233.19)
$ 87.28-63%Reduce -14.36%1,509,122
VRXPrivate Capital 2015-09-30 Reduce-0.14%$158.08 - $262.52
($233.19)
$ 87.28-63%Reduce -1.91%296,931
VRXJohn Paulson 2015-09-30 Reduce-0.12%$158.08 - $262.52
($233.19)
$ 87.28-63%Reduce -1.22%8,890,000
VRXJoel Greenblatt 2015-09-30 Add0.05%$158.08 - $262.52
($233.19)
$ 87.28-63%Add 44.95%88,677
VRXRuane Cunniff 2015-09-30 Add0.03%$158.08 - $262.52
($233.19)
$ 87.28-63%Add 0.11%33,922,192
VRXGeorge Soros 2015-09-30 Sold Out -0.02%$158.08 - $262.52
($233.19)
$ 87.28-63%Sold Out0
VRXKen Fisher 2015-09-30 Add$158.08 - $262.52
($233.19)
$ 87.28-63%Add 0.27%1,833
VRXJohn Paulson 2015-06-30 Add7.33%$197.39 - $241.73
($221.34)
$ 87.28-61%Add 339.02%9,000,000
VRXLou Simpson 2015-06-30 Reduce-1.16%$197.39 - $241.73
($221.34)
$ 87.28-61%Reduce -8.97%1,728,265
VRXWallace Weitz 2015-06-30 Reduce-1.08%$197.39 - $241.73
($221.34)
$ 87.28-61%Reduce -21.86%716,730
VRXGlenn Greenberg 2015-06-30 Reduce-1.07%$197.39 - $241.73
($221.34)
$ 87.28-61%Reduce -2.99%5,701,010
VRXSteve Mandel 2015-06-30 Reduce-0.2%$197.39 - $241.73
($221.34)
$ 87.28-61%Reduce -4.66%5,310,143
VRXRuane Cunniff 2015-06-30 Reduce-0.19%$197.39 - $241.73
($221.34)
$ 87.28-61%Reduce -0.60%33,884,050
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pearson J. MichaelCEO 2015-11-05Sell1,297,399$78.489.53view
Farmer Ronald HaroldDirector 2015-10-21Buy1,500$181.6-52.67view
Farmer Ronald HaroldDirector 2015-08-26Buy500$220-60.93view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.97-61.79view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-66.19view
Rosiello Robert L.Executive Vice President 2015-06-12Buy12,900$232.51-63.03view
UBBEN JEFFREY W 2015-06-10Sell4,200,000$220.24-60.97view
Farmer Ronald HaroldDirector 2015-06-09Buy1,000$260.63-67.02view
Mirovsky PavelEVP, Pres. & GM Valeant EMENA 2015-06-02Sell38,000$238.01-63.88view
Whitaker Anne ClemDirector 2015-05-26Buy7,500$234.67-63.37view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
In Vast Difference From Berkshire Style, Lou Simpson Adds to Valeant Position Feb 08 2016 
Lou Simpson Adds to Valeant Stake Feb 07 2016 
So, Bill Ackman Makes Some Good Points on the Index Bubble… Feb 05 2016 
Valeant's Share Price Continues to Decline Feb 05 2016 
Whitney Tilson's New Emails to Partners Feb 05 2016 
Leith Wheeler Investment Funds 4th Quarter Review Jan 29 2016 
Pershing Square's New Presentation, Part 1 Jan 29 2016 
Steven Romick Reduces 7 Stakes in 4th Quarter Jan 28 2016 
Bill Ackman Comments on Valeant Jan 27 2016 
Bill Ackman's Pershing Square Annual Investor Letter Jan 27 2016 

More From Other Websites
Bill Ackman's 2 Best Investments (GGP, CP) Feb 10 2016
Munger Says Couldn't Resist Valeant Critique That Caused Trouble Feb 10 2016
[$$] Three Best Buys in Specialty Pharma Feb 10 2016
The Secret’s Out: This Biotech Just Stunned the World Feb 10 2016
SEC Investigating Ex-Salix Executives Over Misleading Investors Feb 10 2016
Who Will Come Out On Top As Flu Season Draws Down Feb 10 2016
SEC investigating former Salix Pharma execs, Reuters reports Feb 09 2016
Here’s What Wall Street Thinks of Bill Ackman’s New Herbalife Attack Feb 09 2016
SEC probes former Salix CEO, CFO over investor disclosure-source Feb 09 2016
OICisDifferent: The Drug Behind The Super Bowl 50 Constipation Ad Feb 09 2016
Pharming and Cytobioteck Announce Extension of Distribution Agreement for RUCONEST® Feb 09 2016
CANADA STOCKS-TSX falls, pressured by financial and energy stocks Feb 08 2016
Pharma's Unflattering Super Bowl Feb 08 2016
Billionaire Bill Ackman Buys More Valeant Shares, Starboard Value Gradually Jettisons Darden... Feb 08 2016
Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner :... Feb 08 2016
Why Does Valeant’s Valuation Seem to Be at a Discount? Feb 08 2016
Lou Simpson Adds to Valeant Stake Feb 07 2016
5 Trade ideas for Monday: JP Morgan, Norfolk Southern, P&G, Raytheon and Valeant Feb 07 2016
Congress unites in scorn for Shkreli, but gridlock remains Feb 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK